Cite This Page
Bibliographic details for Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study
- Page name: Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 10 January 2024 08:29 UTC
- Date retrieved: 15 June 2024 03:31 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658
- Page Version ID: 474658
Citation styles for Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study
APA style
Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study. (2024, January 10). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 03:31, June 15, 2024 from https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658.
MLA style
"Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 10 Jan 2024, 08:29 UTC. 15 Jun 2024, 03:31 <https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 10 January 2024, 08:29 UTC, <https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658> [accessed 15 June 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658 (accessed June 15, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 10, 08:29 UTC [cited 2024 Jun 15]. Available from: https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658.
Bluebook style
Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study, https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658 (last visited June 15, 2024).
BibTeX entry
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658", note = "[Online; accessed 15-June-2024]" }
When using the LaTeX package url (\usepackage{url}
somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Security and efficiency regarding antiprogrammed cell death1 monoclonal antibodies before allogeneic hematopoietic mobile hair transplant with regard to relapsed or perhaps refractory Hodgkin lymphoma a multicenter retrospective study --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "\url{https://news.npo.digital/index.php?title=Security_and_efficiency_regarding_antiprogrammed_cell_death1_monoclonal_antibodies_before_allogeneic_hematopoietic_mobile_hair_transplant_with_regard_to_relapsed_or_perhaps_refractory_Hodgkin_lymphoma_a_multicenter_retrospective_study&oldid=474658}", note = "[Online; accessed 15-June-2024]" }